Current and New Treatments for Diabetes 2019

Research Objectives:

  • Understand patient characteristics and current treatments for Type 2 Diabetes
  • Explore what physicians need for future Type 2 Diabetes treatment and what they are most excited about

Method: 5-minute MicroSurvey via InCrowd
Crowds: US Endocrinologists, US Primary Care Physicians
Sample Size: n=85
Fielding Period: May 30, 2019
Screening Criteria: Qualified respondents are US-based endocrinologists and PCPs who treat at least 20 Type 2 Diabetes (T2D) patients in a typical month.

One key finding:

  • In terms of future developments, physicians are excited about several new options including oral GLP-1 RAs, new medication options with less frequent dosing, and enhanced diabetes management devices.

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Instant Insights – Weight Loss Drugs

Instant Insights – Weight Loss Drugs

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...

read more
Post-ASCO Excitement Report

Post-ASCO Excitement Report

Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...

read more
2023 Q1 – NSCLC Essentials Readout

2023 Q1 – NSCLC Essentials Readout

Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...

read more